Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study.

Ren Fail · 2022 · PMC8890585 · PMID 35220855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The total count of T-spots (a sum of spots to both spike and nucleocapside structural peptides) was significantly lower in the control group than in patients receiving HD at weeks 10 ( p = 0.019) and 26 ( p = 0.0098) after COVID-19 diagnosis, whereas this finding did not reach statistical significance at week 18 ( Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.